LOGIQ E10s, LOGIQ Fortis
by Ge Medical Systems Ultrasound and Primary Care Diagnostic,
510(k) K231989
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK231989 | Date7 Nov 2023 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- IYN
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.1550
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Logiq E10s and Logiq Fortis are ultrasound systems designed for general imaging. These devices provide imaging capabilities to assist clinicians in scanning, diagnosing, and treating a wide range of patients across a broad spectrum of conditions.
These systems feature artificial intelligence-based decision support and workflow solutions to enhance productivity. The devices are authorized under FDA 510k clearance, identified by k-number K231989.
Other devices from Ge Medical Systems Ultrasound and Primary Care Diagnostic,
Questions
AI-generated answers, 24 Sep 2026
What are the LOGIQ E10s and LOGIQ Fortis systems used for?
These ultrasound systems are designed for general imaging applications. They provide clinicians with the necessary imaging capabilities to assist in the scanning, diagnosis, and treatment of a wide range of patients across a broad spectrum of medical conditions.
Do these ultrasound systems include automated features?
Yes, both the LOGIQ E10s and LOGIQ Fortis incorporate artificial intelligence-based decision support and workflow solutions. These features are integrated into the systems to help enhance clinical productivity during diagnostic procedures.
What is the regulatory status of these devices?
The LOGIQ E10s and LOGIQ Fortis systems are authorized under FDA 510k clearance, identified by k-number K231989. The submission was processed as a traditional 510k, resulting in a determination of substantial equivalence.